Kewaunee Scientific (KEQU) Cash & Equivalents (2010 - 2026)

Kewaunee Scientific's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $8.2 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 182.99% year-over-year to $8.2 million; the TTM figure through Jan 2026 stood at $8.2 million (up 182.99% YoY), while the FY2025 annual figure was $14.9 million, up 459.42% from the prior year.
• Cash & Equivalents was $8.2 million for Q1 2026 at Kewaunee Scientific, down from $12.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $26.0 million in Q4 2024 to a low of $975000.0 in Q3 2024.
• Historically, Cash & Equivalents has averaged $11.0 million across 5 years, with a median of $12.6 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents tumbled 92.32% in 2024, then soared 1898.87% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $9.4 million in 2022, then soared by 45.68% to $13.7 million in 2023, then soared by 89.21% to $26.0 million in 2024, then slumped by 51.49% to $12.6 million in 2025, then sank by 35.26% to $8.2 million in 2026.
• The last three Cash & Equivalents figures came in at $8.2 million (Q1 2026), $12.6 million (Q4 2025), and $19.5 million (Q3 2025), per Business Quant data.